Meckel’s diverticulum as a cause of abdominal emergency

Summary

Introduction:

Meckel’s diverticulum is a small intestine malformation that develops in the embryonic phase and can cause sudden abdominal incidents. It affects approximately 2% of the population, which makes it the second most common birth defect of the digestive tract. Most often, symptomatic diverticulum occurs in the male population and its most frequent manifestation is bleeding into the gastrointestinal tract. The intestinal wall may be affected by inflammation, and the diverticulum may cause intestinal obstruction with connective tissues.

Material and methodology:

The group comprised 35 patients who were hospitalized at the surgical clinic of the faculty hospital from January 1^st 2012 to November 1^st 2017 and who were newly diagnosed with Meckel’s diverticulum. The exclusion criterion was its known presence before January 1^st 2012. All the diagnoses were made using perioperative screening/examination followed by histological examinations in the case of resection.

Results:

Meckel’s diverticulum was the cause of difficulty in 16 cases. Most commonly, the diverticulum was inflamed, and less commonly, there was bleeding, and exceptionally an ileus, caused by adhesions between diverticulum and abdominal wall. Patients tended to be male and below the age of 18. Females, on the other hand, suffered more often from a random diagnosis of asymptomatic Meckel’s diverticulum.

Conclusion:

The occurrence of Meckel’s diverticulum is not very common; however, its presence must be considered in cases of sudden abdominal accidents, in cases of inflammation, and in cases of bleeding at any age. Symptomatic Meckel’s diverticulum is indicated for resection, and asymptomatic diverticulum may be left in situ on condition of obtaining the patient’s or parent’s consent, together with thorough medical documentation.

Key words:

Meckel’s diverticulum –⁠ abdominal emergency –⁠ congenital malformation of gastrointestinal tract.

Submitted: 7. 9. 2018

Accepted: 17. 9. 2018

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for bio­­­­medical papers.